Mallinckrodt (MNK) Tops Q3 EPS by 23c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Leerink Partners Upgrades Mallinckrodt plc (MNK) to Outperform on Valuation
August 6, 2015 2:40 PM EDTLeerink Partners upgraded Mallinckrodt plc (NYSE: MNK) from Market Perform to Outperform with a price target of $112. Analyst Jason M. Gerberry tied the upgrade to valuation.
"We are upgrading MNK on valuation as the stocks recent plummet post F3Q has created a buying opportunity, in our... More
Piper Jaffray Cuts Price Target on Mallinckrodt (MNK) to $140 Following 3Q EPS Beat
August 5, 2015 9:40 AM EDTPiper Jaffray reiterated an Overweight rating on Mallinckrodt plc (NYSE: MNK), and cut the price target to $140.00 (from $150.00), following 3Q15 results. Mallinckrodt reported 3Q15 diluted EPS of $2.05, ahead of the Street estimate of $1.83. Revenues of $965M missed the Street's $986M estimate.
Analyst David Amsellem commented, "Mallinckrodt reported fiscal... More
Mallinckrodt (MNK) PT, Estimates Lowered at Leerink Partners Following Mixed Q3
August 5, 2015 7:48 AM EDTLeerink Partners analyst Jason Gerberry lowered estimates and his price target on Market Perform-rated Mallinckrodt plc (NYSE: MNK) to $112.00 (from $133.00) following mixed Q3 results that included a ~$20m miss on consensus due to weaker than expected Acthar (autoimmune disease) and oxycodone Gx... More
JPMorgan Downgrades Mallinckrodt plc (MNK) to Neutral
August 5, 2015 7:10 AM EDTJPMorgan downgraded Mallinckrodt plc (NYSE: MNK) from Overweight to Neutral with a price target of $120.00 (from $140.00).
For an analyst ratings summary and ratings history on Mallinckrodt plc click here. For more ratings news on Mallinckrodt plc click here.
Shares of Mallinckrodt plc closed at $106.73 yesterday.
... More